![Pharmacy Times](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/334/normal/Screen_Shot_2015-01-26_at_11.48.35.png?1422272928)
Estrogen Receptor Beta Shown to Act as Tumor Suppressor in Patients with Inflammatory Breast Cancer
Pharmacy Times,
Estrogen receptor beta (ERβ) was shown to act as a mediator of estrogen signaling and a tumor suppressor in inflammatory breast…
Estrogen receptor beta (ERβ) was shown to act as a mediator of estrogen signaling and a tumor suppressor in inflammatory breast…
The prognosis of recurrent/metastatic SS remains poor, highlighting the need for a novel therapeutic strategy.
The mechanisms underlying the observed effects of progesterone on breast cancer outcomes are unclear.
[...] we demonstrated that the combination of Nerofe and DOX exerts a synergistic effect during mCRC treatment [...]
In an editorial published inOncotarget, entitled, ER as a mediator of oestrogen signalling in inflammatory breast cancer",researc…
A new editorial paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, "ERβ as a mediator of estrogen…
A new editorial paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, "ERβ as a mediator of estrogen…
A new editorial paper titled " " has been published in Oncotarget. In this new editorial, researchers Harika Nagandla and…
“The mechanism of the anti-metastatic activity of ERβ was investigated […]” Credit: 2023 Nagandla and Thomas.
Credit: 2023 Nagandla and Thomas. “The mechanism of the anti-metastatic activity of ERβ was investigated […]” BUFFALO, NY- July…
"The mechanism of the anti-metastatic activity of ERβ was investigated [...]" BUFFALO, NY- July 3, 2023 – A new editorial paper…
The mechanism of the anti-metastatic activity of ER was investigated [...] BUFFALO, NY- July 3, 2023 A new editorial paper was…
The mechanism of the anti-metastatic activity of ER was investigated [...]